Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

Prognostic value of circulating tumor DNA following local therapy in colorectal cancer with liver metastases. Diagnostic performance of endoscopy and MRI in identifying true response among patients ...

Bitcoin is rated 'Strong Buy' due to robust network value, user growth, and an attractive current entry point. Read what investors need to know.

The US is making plans to try to intercept a fleeing oil tanker that Russia has claimed jurisdiction over, according to four people familiar with the matter, setting up a possible confrontation ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

Three Russian MiG-31 Foxhound fighters violated Estonian airspace, prompting the scramble of two Italian F-35s to intercept them. Three MiG-31 Foxhound fighters of the Russian Aerospace Forces entered ...

NATO jets intercepted two Russian SU-30 warplanes carrying supersonic missiles over the Baltic Sea as Vladimir Putin continues to taunt the West with aggressive shows of Moscow's military strength.

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...